{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T10:58:10Z","timestamp":1791197890120,"version":"4.1.0"},"reference-count":51,"publisher":"MDPI AG","issue":"21","license":[{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Background: Inflammatory bowel disease (IBD), encompassing ulcerative colitis (UC) and Crohn\u2019s disease (CD), is characterized by chronic intestinal inflammation with fluctuating clinical severity. Although fecal calprotectin (FC) and fecal occult blood (FOBT) are established noninvasive biomarkers of intestinal inflammation, their interplay with nutritional status and disease activity has not been fully elucidated. This study aimed to explore the relationship between FC, FOBT, and disease activity in IBD, and to assess the potential mediating role of nutritional status as measured by the prognostic nutritional index (PNI). Methods: This retrospective study includes 128 adult patients with confirmed IBD (50 UC and 78 CD) examined at a tertiary care center between December 2023 and August 2025. Disease activity was assessed using the Mayo score for UC and the Harvey\u2013Bradshaw Index for CD. FC levels were quantitatively measured using an enzyme-linked immunosorbent assay (ELISA), and fecal occult blood testing was performed with an automated latex agglutination-based system. Multivariable linear regression models were conducted to identify independent predictors of disease activity. Results: UC patients had significantly higher FC levels (278.0 vs. 133.5 \u00b5g\/g, p &lt; 0.001), FOBT positivity rates (76.7% vs. 43.6%, p = 0.002), and lower PNI (49.2 \u00b1 4.2 vs. 51.5 \u00b1 4.6, p = 0.048) compared to CD patients. In both UC and CD, disease activity scores were positively correlated with FC, FOBT positivity, CRP, and duration of illness, and negatively correlated with PNI (p &lt; 0.05). In multivariable regression, PNI lost predictive value when FC and FOBT were included; FC and FOBT remained strong independent predictors of disease activity. Conclusions: FC and fecal occult blood are independently associated with higher disease activity in IBD, and may mediate the observed relationship between poor nutritional status and inflammation severity. The loss of significance of PNI in adjusted models suggests that intestinal inflammation and bleeding may act as intermediaries linking malnutrition to disease activity.<\/jats:p>","DOI":"10.3390\/nu17213379","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T13:59:36Z","timestamp":1761659976000},"page":"3379","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The Relationship Between Disease Activity and Fecal Calprotectin and Fecal Occult Blood in Inflammatory Bowel Disease: The Role of Nutritional Status"],"prefix":"10.3390","volume":"17","author":[{"given":"Ali","family":"Bilgen","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Private Anka Hospital, \u015eehitkamil District, 99 Number Street, No. 162, Gaziantep 27590, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hale","family":"Akp\u0131nar","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Faculty of Medicine, Dokuz Eylul University, \u0130zmir 35340, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,10,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"5A","DOI":"10.1155\/2005\/269076","article-title":"Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology","volume":"19","author":"Silverberg","year":"2005","journal-title":"Can. J. Gastroenterol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00054725-200002000-00002","article-title":"A simple classification of Crohn\u2019s disease: Report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998","volume":"6","author":"Gasche","year":"2000","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1046\/j.1365-2796.2002.01067.x","article-title":"Inflammatory bowel disease: New insights into pathogenesis and treatment","volume":"252","author":"Ardizzone","year":"2002","journal-title":"J. Intern. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"384","DOI":"10.14309\/ajg.0000000000000152","article-title":"ACG Clinical Guideline: Ulcerative Colitis in Adults","volume":"114","author":"Rubin","year":"2019","journal-title":"Am. J. Gastroenterol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.gtc.2012.01.007","article-title":"Fecal markers: Calprotectin and lactoferrin","volume":"41","author":"Abraham","year":"2012","journal-title":"Gastroenterol. Clin."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Fu, Y., Wang, L., Xie, C., Zou, K., Tu, L., Yan, W., and Hou, X. (2017). Comparison of non-invasive biomarkers faecal BAFF, calprotectin and FOBT in discriminating IBS from IBD and evaluation of intestinal inflammation. Sci. Rep., 7.","DOI":"10.1038\/s41598-017-02835-5"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1093\/ibd\/izae005","article-title":"Diagnostic Performance of a Fecal Calprotectin Assay as a Biomarker for Mayo Endoscopic Subscore in Ulcerative Colitis: Result From a Tertiary Referral Center","volume":"30","author":"Suttichaimongkol","year":"2024","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Kawashima, K., Ishihara, S., Yuki, T., Fukuba, N., Oshima, N., Kazumori, H., Sonoyama, H., Yamashita, N., Tada, Y., and Kusunoki, R. (2016). Fecal calprotectin level correlated with both endoscopic severity and disease extent in ulcerative colitis. BMC Gastroenterol., 16.","DOI":"10.1186\/s12876-016-0462-z"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Li, J., Xu, M., Qian, W., Ling, F., Chen, Y., Li, S., Cheng, Y., and Zhu, L. (2023). Clinical value of fecal calprotectin for evaluating disease activity in patients with Crohn\u2019s disease. Front. Physiol., 14.","DOI":"10.3389\/fphys.2023.1186665"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Durham, K., Atagozli, T., Elliott, D.E., and Ince, M.N. (2025). Laboratory Tests in Inflammatory Bowel Disease: An Evidence-Based Approach to Daily Practice. Biomedicines, 13.","DOI":"10.3390\/biomedicines13020491"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.3748\/wjg.v16.i9.1110","article-title":"Prediction of flare-ups of ulcerative colitis using quantitative immunochemical fecal occult blood test","volume":"16","author":"Kuriyama","year":"2010","journal-title":"World J. Gastroenterol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/ibd\/izy212","article-title":"Sarcopenia and Inflammatory Bowel Disease: A Systematic Review","volume":"25","author":"Ryan","year":"2019","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Profir, M., Enache, R.M., Rosu, O.A., Pavelescu, L.A., Cretoiu, S.M., and Gaspar, B.S. (2025). Malnutrition and Its Influence on Gut sIgA\u2013Microbiota Dynamics. Biomedicines, 13.","DOI":"10.3390\/biomedicines13010179"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s43166-024-00289-y","article-title":"Sarcopenia and low prognostic nutritional index as markers of disease activity in patients with inflammatory bowel disease and predictors of poor outcome: A cohort longitudinal study","volume":"51","author":"Sherif","year":"2024","journal-title":"Egypt. Rheumatol. Rehabil."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.3748\/wjg.v25.i28.3823","article-title":"Systematic review of nutrition screening and assessment in inflammatory bowel disease","volume":"25","author":"Li","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"8008","DOI":"10.3748\/wjg.v23.i45.8008","article-title":"Albumin as a prognostic marker for ulcerative colitis","volume":"23","author":"Khan","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0140-6736(80)92767-1","article-title":"A simple index of Crohn\u2019s-disease activity","volume":"315","author":"Harvey","year":"1980","journal-title":"Lancet"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJM198712243172603","article-title":"Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study","volume":"317","author":"Schroeder","year":"1987","journal-title":"N. Engl. J. Med."},{"key":"ref_19","first-page":"1001","article-title":"[Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients]","volume":"85","author":"Onodera","year":"1984","journal-title":"Nihon Geka Gakkai Zasshi"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"11021","DOI":"10.2147\/JIR.S519037","article-title":"Prognostic Nutritional Index is A Useful Predictive Marker for Morbidity and Mortality in Surgery for Perforated Peptic Ulcer","volume":"18","author":"Jia","year":"2025","journal-title":"J. Inflamm. Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"142","DOI":"10.4274\/tod.galenos.2024.50490","article-title":"Prognostic Nutritional Index in Patients with Both Vertebral and Non-Vertebral Osteoporotic Fractures","volume":"30","year":"2024","journal-title":"Turk. J. Osteoporos."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Wei, J., Lu, J., Jia, H., Yang, X., Guo, X., Liu, J., and Li, X. (2023). Value of a preoperative prognostic nutritional index for the prognostic evaluation of gastric neuroendocrine carcinoma patients. Front. Nutr., 10.","DOI":"10.3389\/fnut.2023.1043550"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Castiglione, V., Berodes, M., Lukas, P., Louis, E., Cavalier, E., and Lutteri, L. (2022). New Faecal Calprotectin Assay by IDS: Validation and Comparison to DiaSorin Method. Diagnostics, 12.","DOI":"10.3390\/diagnostics12102338"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Jain, A.V., Gopal, S., Shetty, A.J., Shenoy, S., Tantry, B.V., Unnikrishnan, B., Holla, R., and Anand, R. (2025). Predictive accuracy of fecal calprotectin in assessing clinical activity and disease severity in patients with Ulcerative Colitis and Crohn\u2019s disease. BMC Gastroenterol., 25.","DOI":"10.1186\/s12876-025-04035-2"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1590\/S1807-59322009000500009","article-title":"The role of fecal calprotectin in investigating inflammatory bowel diseases","volume":"64","author":"Erbayrak","year":"2009","journal-title":"Clinics"},{"key":"ref_26","first-page":"21","article-title":"Fecal calprotectin in inflammatory bowel disease","volume":"9","author":"Walsham","year":"2016","journal-title":"Clin. Exp. Gastroenterol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3904\/kjim.2016.324","article-title":"The usefulness of fecal calprotectin in assessing inflammatory bowel disease activity","volume":"34","author":"Lee","year":"2019","journal-title":"Korean J. Intern. Med."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Desalegn, Z., Bane, A., Merdasa, G., and Arota, A. (2025). Active Disease and Its Associated Factors Among Patients with Inflammatory Bowel Disease in Addis Ababa Ethiopia: A Hospital-Based Cross-Sectional Study. Front. Gastroenterol., 4.","DOI":"10.3389\/fgstr.2025.1569933"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Ortega-Zapero, M., Gomez-Bris, R., Pascual-Laguna, I., Saez, A., and Gonzalez-Granado, J.M. (2025). Neutrophils and NETs in Pathophysiology and Treatment of Inflammatory Bowel Disease. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26157098"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/jgh3.12068","article-title":"Fecal calprotectin correlates with active colonic inflammatory bowel disease but not with small intestinal Crohn\u2019s disease activity","volume":"2","author":"Zittan","year":"2018","journal-title":"JGH Open"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Lee, E., Lee, G.H., Park, B., Ahn, S.S., and Noh, C.K. (2023). Positive faecal immunochemical test predicts the onset of inflammatory bowel disease: A nationwide, propensity score-matched study. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1128736"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"5","DOI":"10.5217\/ir.2016.14.1.5","article-title":"Fecal immunochemical test as a biomarker for inflammatory bowel diseases: Can it rival fecal calprotectin?","volume":"14","author":"Kato","year":"2016","journal-title":"Intest. Res."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Bueno-Hernandez, N., Yamamoto-Furusho, J.K., and Mendoza-Martinez, V.M. (2025). Nutrition in Inflammatory Bowel Disease: Strategies to Improve Prognosis and New Therapeutic Approaches. Diseases, 13.","DOI":"10.3390\/diseases13050139"},{"key":"ref_34","first-page":"469","article-title":"Differences in dietary habits between patients with inflammatory bowel disease in clinical remission and a healthy population","volume":"31","author":"Principi","year":"2018","journal-title":"Ann. Gastroenterol."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Jablonska, B., and Mrowiec, S. (2023). Nutritional Status and Its Detection in Patients with Inflammatory Bowel Diseases. Nutrients, 15.","DOI":"10.3390\/nu15081991"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Balestrieri, P., Ribolsi, M., Guarino, M.P.L., Emerenziani, S., Altomare, A., and Cicala, M. (2020). Nutritional Aspects in Inflammatory Bowel Diseases. Nutrients, 12.","DOI":"10.3390\/nu12020372"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Kilby, K., Mathias, H., Boisvenue, L., Heisler, C., and Jones, J.L. (2019). Micronutrient Absorption and Related Outcomes in People with Inflammatory Bowel Disease: A Review. Nutrients, 11.","DOI":"10.3390\/nu11061388"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"otaf043","DOI":"10.1093\/crocol\/otaf043","article-title":"Fecal Calprotectin and C-Reactive Protein Association With Histologic and Endoscopic Endpoints in Mirikizumab-Treated Patients With Ulcerative Colitis","volume":"7","author":"Panaccione","year":"2025","journal-title":"Crohns Colitis 360"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Riaz, B., and Sohn, S. (2023). Neutrophils in Inflammatory Diseases: Unraveling the Impact of Their Derived Molecules and Heterogeneity. Cells, 12.","DOI":"10.3390\/cells12222621"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"17562848231155987","DOI":"10.1177\/17562848231155987","article-title":"Pursuing neutrophils: Systematic scoping review on blood-based biomarkers as predictors of treatment outcomes in inflammatory bowel disease","volume":"16","author":"Magalhaes","year":"2023","journal-title":"Ther. Adv. Gastroenterol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1258\/acb.2012.011272","article-title":"Between-assay variability of faecal calprotectin enzyme-linked immunosorbent assay kits","volume":"50","author":"Whitehead","year":"2013","journal-title":"Ann. Clin. Biochem."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1097\/MCG.0000000000001460","article-title":"Can 2 Different Fecal Calprotectin Assays be Used Interchangeably in IBD Treatment?","volume":"56","author":"Diederen","year":"2022","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/s41586-025-08940-0","article-title":"Global evolution of inflammatory bowel disease across epidemiologic stages","volume":"642","author":"Hracs","year":"2025","journal-title":"Nature"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Zhao, R., Zhao, L., Gao, X., Yang, F., Yang, Y., Fang, H., Ju, L., Xu, X., Guo, Q., and Li, S. (2022). Geographic Variations in Dietary Patterns and Their Associations with Overweight\/Obesity and Hypertension in China: Findings from China Nutrition and Health Surveillance (2015\u20132017). Nutrients, 14.","DOI":"10.3390\/nu14193949"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e065186","DOI":"10.1136\/bmjopen-2022-065186","article-title":"Global, regional and national burden of inflammatory bowel disease in 204 countries and territories from 1990 to 2019: A systematic analysis based on the Global Burden of Disease Study 2019","volume":"13","author":"Wang","year":"2023","journal-title":"BMJ Open"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"160","DOI":"10.5217\/ir.2018.00114","article-title":"Does fecal calprotectin equally and accurately measure disease activity in small bowel and large bowel Crohn\u2019s disease?: A systematic review","volume":"17","author":"Simon","year":"2019","journal-title":"Intest. Res."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Barberio, B., Bertin, L., Facchin, S., Bonazzi, E., Cusano, S., Romanelli, G., Pesenti, F.F., Cazzaniga, E., Palestini, P., and Zingone, F. (2025). Dietary Interventions and Oral Nutritional Supplementation in Inflammatory Bowel Disease: Current Evidence and Future Directions. Nutrients, 17.","DOI":"10.20944\/preprints202504.1327.v1"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Geesala, R., Gongloor, P., Recharla, N., and Shi, X.Z. (2024). Mechanisms of Action of Exclusive Enteral Nutrition and Other Nutritional Therapies in Crohn\u2019s Disease. Nutrients, 16.","DOI":"10.3390\/nu16213581"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.clnu.2022.12.004","article-title":"ESPEN guideline on Clinical Nutrition in inflammatory bowel disease","volume":"42","author":"Bischoff","year":"2023","journal-title":"Clin. Nutr."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/ajg.2015.233","article-title":"Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target","volume":"110","author":"Sandborn","year":"2015","journal-title":"Am. J. Gastroenterol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11894-025-00991-7","article-title":"Applying Biomarkers in Treat-to-target Approach for IBD","volume":"27","author":"Lutz","year":"2025","journal-title":"Curr. Gastroenterol. Rep."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/17\/21\/3379\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T02:32:59Z","timestamp":1761705179000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/17\/21\/3379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,28]]},"references-count":51,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["nu17213379"],"URL":"https:\/\/doi.org\/10.3390\/nu17213379","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,28]]}}}